Brooks Labs confirms non-applicability of Large Corporate framework for FY26

BROOKS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-8.3%1-day move

₹58.90

prior close

₹58.86

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-2.8-1.3-1.5-1.5-8.3-8.1-8.3-10.8-15.2-15.4-8.8+16.4+16.9—

Up moveDown movePending

AI summary

Brooks Laboratories filed its initial disclosure under SEBI's Large Corporate (LC) framework for FY ending March 31, 2026. The company confirmed it does NOT qualify as a Large Corporate under the SEBI circular dated October 19, 2023. Outstanding borrowings stood at just Rs. 1.19 crore, well below the LC threshold. Credit rating is CARE BB; Stable / CARE A4 from CareEdge Ratings. Since it is not classified as a Large Corporate, no mandatory debt security borrowing or shortfall fine applies.

Likely market impact

Neutral for shareholders — routine compliance filing. Low debt and no obligation to raise funds via bond market under SEBI's LC rules.